Literature DB >> 25057976

Optic pathway gliomas: a review.

Iris Fried1, Uri Tabori, Tarik Tihan, Arun Reginald, Eric Bouffet.   

Abstract

Optic pathway gliomas account for 3-5% of all pediatric CNS tumors and represent the most common intrinsic optic nerve tumors. These tumors occur preferentially during the first decade of life and are particularly frequent in children with neurofibromatosis type 1. Although optic pathway gliomas are low-grade tumors, their behavior can be aggressive, and their management is often challenging. Their management includes observation, surgery, chemotherapy and radiation. The role of each modality is discussed as well as current and future developments in treatment, in particular targeted therapies that are currently being investigated.

Entities:  

Mesh:

Year:  2013        PMID: 25057976      PMCID: PMC6169473          DOI: 10.2217/cns.12.47

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


  117 in total

1.  [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].

Authors:  A K Gnekow; P Kaatsch; R Kortmann; O D Wiestler
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

2.  Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?

Authors:  Darcy H Wolsey; Scott A Larson; Donnel Creel; Robert Hoffman
Journal:  J AAPOS       Date:  2006-08       Impact factor: 1.220

3.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

Authors:  Eric Bouffet; Regina Jakacki; Stewart Goldman; Darren Hargrave; Cynthia Hawkins; Manohar Shroff; Juliette Hukin; Ute Bartels; Nicholas Foreman; Stewart Kellie; Joanne Hilden; Michael Etzl; Beverly Wilson; Derek Stephens; Uri Tabori; Sylvain Baruchel
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

4.  Magnetic resonance diffusion tensor imaging of the optic nerves to guide treatment of pediatric suprasellar tumors.

Authors:  Michael B Salmela; Keith A Cauley; Trevor Andrews; Jay V Gonyea; Izabela Tarasiewicz; Christopher G Filippi
Journal:  Pediatr Neurosurg       Date:  2010-01-26       Impact factor: 1.162

5.  Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).

Authors:  A K Gnekow; R-D Kortmann; T Pietsch; A Emser
Journal:  Klin Padiatr       Date:  2004 Nov-Dec       Impact factor: 1.349

Review 6.  Late-onset optic pathway tumors in children with neurofibromatosis 1.

Authors:  R Listernick; R E Ferner; L Piersall; S Sharif; D H Gutmann; J Charrow
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

7.  Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

Authors:  R J Packer; J Ater; J Allen; P Phillips; R Geyer; H S Nicholson; R Jakacki; E Kurczynski; M Needle; J Finlay; G Reaman; J M Boyett
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

8.  Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas.

Authors:  Ute Bartels; Cynthia Hawkins; Ma Jing; Michael Ho; Peter Dirks; James Rutka; Derek Stephens; Eric Bouffet
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

9.  Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.

Authors:  R Listernick; J Charrow; M Greenwald; M Mets
Journal:  J Pediatr       Date:  1994-07       Impact factor: 4.406

10.  Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function.

Authors:  Thomas E Merchant; Chia-Ho Hua; Hemant Shukla; Xiaofei Ying; Simeon Nill; Uwe Oelfke
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

View more
  21 in total

Review 1.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

2.  Occurrence of Second Primary Malignancies in Patients With Primary Optic Nerve Gliomas: A Surveillance, Epidemiology, and End Results Analysis.

Authors:  Zain Hussain; Jawad Khan; Amir Saeed; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-11-03

3.  Optic Nerve Glioma in Neurofibromatosis: Radiological Clues to Diagnosis in a Young Child.

Authors:  Harsh Patel; Biswaroop Chakrabarty; Rachna Dubey; Atin Kumar; Sheffali Gulati
Journal:  J Pediatr Neurosci       Date:  2021-07-12

Review 4.  Endoscopic transnasal surgery in optic pathway gliomas located in the chiasma-hypothalamic region: case series of ten patients in a single-center experience and endoscopic literature review.

Authors:  Eren Yilmaz; Atakan Emengen; Ecem Cemre Ceylan; Burak Cabuk; Ihsan Anik; Savas Ceylan
Journal:  Childs Nerv Syst       Date:  2022-09-10       Impact factor: 1.532

5.  Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience.

Authors:  Giada Del Baldo; Antonella Cacchione; Vito Andrea Dell'Anna; Pietro Merli; Giovanna Stefania Colafati; Antonio Marrazzo; Sabrina Rossi; Isabella Giovannoni; Sabina Barresi; Annalisa Deodati; Paola Valente; Elisabetta Ferretti; Mara Capece; Angela Mastronuzzi; Andrea Carai
Journal:  Front Surg       Date:  2022-06-16

6.  Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Andrea Maria Cappellano; Nasjla Saba da Silva; Paula Yuri Sacai; Frederico Adolfo B Silva; Arthur Gustavo Fernandes; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2018-05-15       Impact factor: 2.379

7.  Endoscopic transnasal resection of optic pathway pilocytic astrocytoma.

Authors:  Sarah Bin Abdulqader; Ziyad Al-Ajlan; Abdulrahman Albakr; Wisam Issawi; Mohammed Al-Bar; Pablo F Recinos; Saad Alsaleh; Abdulrazag Ajlan
Journal:  Childs Nerv Syst       Date:  2018-10-18       Impact factor: 1.475

8.  The role of imaging features and resection status in the survival outcome of sporadic optic pathway glioma children receiving different adjuvant treatments.

Authors:  Zhi-Ming Liu; Chi-Hyi Liao; Xu An; Wen-Tao Zhou; Zhen-Yu Ma; Wei Liu; Yong-Ji Tian
Journal:  Neurosurg Rev       Date:  2022-02-01       Impact factor: 3.042

9.  Optic nerve glioma with complete intraocular extension.

Authors:  Masoomeh Eghtedari; Seyede Fariba Fattahi; Naser Owji; Mohammad Javad Ashraf; Mohammad Reza Khalili; Bita Geramizadeh
Journal:  J Curr Ophthalmol       Date:  2016-08-03

10.  Detection and characterisation of visual field defects using Saccadic Vector Optokinetic Perimetry in children with brain tumours.

Authors:  Ian C Murray; Conrad Schmoll; Antonios Perperidis; Harry M Brash; Alice D McTrusty; Lorraine A Cameron; Alastair G Wilkinson; Alan O Mulvihill; Brian W Fleck; Robert A Minns
Journal:  Eye (Lond)       Date:  2018-06-07       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.